Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 24: Day 2 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 2 of the ESC Congress 2024 was packed with important data for cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to summarise the key take-home messages from hot line trials presented on day.Day 2 Highlights:00:24-03:02: NOTION-3: Percutaneous coronary intervention in patients undergoing… View more

Intervention

Anticoagulation
RELAXIN-LA Trial: Volenrelaxin Linked to Worsening Congestion in HFpEF
Added: 7 months ago Source:  Radcliffe Cardiology
Treatment with volenrelaxin, a long-acting human relaxin analogue, was associated with worsening congestion in patients with recently decompensated heart failure with preserved ejection fraction (HFpEF), leading to the early termination of the phase 2 RELAXIN-LA trial.¹ Despite this, the lowest dose of the drug did show an improvement in the study's primary endpoint.Relaxin is a peptide hormone… View more

Imaging & Diagnostics

Cardiovascular Kidney Metabolic
Social Factors Impact Outcomes in HCM Patients
Added: 3 months ago Source:  Radcliffe Cardiology
While social determinants of health (SDOH) are known to influence outcomes in acquired cardiovascular diseases, their impact on conditions with a strong genetic basis, such as hypertrophic cardiomyopathy (HCM), has been less clear.² A new study using data from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) suggests that area-based social factors are independently associated with adverse… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
David A Baran
Research Area(s) / Expertise:
Personal History Dr David Alan Baran is a Cardiologist from Parsippany, New Jersey. He is married and based in Norfolk, Virginia. Academic History In 1988, Dr Baran received his Bachelor’s (Hon) in Chemistry from Florida Atlantic University, followed by an M.D. from the University of South Florida Morsani College of Medicine in 1992. He finished his Residency at NY Presbyterian… View more
Research Area(s) / Expertise: Job title: Cardiologist
Dr Michel Komajda is a Cardiologist at theNational Academy of Medicine in Paris, France.He is a past president of the European Society of Cardiology and the French Cardiac Society.He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE,… View more
Development of Small-molecule SERCA Stimulators
Author(s): Antonio Zaza , Marcella Rocchetti Added: 9 months ago

Heart Failure
Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease
Author(s): Federica Piani , Lorenzo Annesi , Claudio Borghi Added: 10 months ago

Prevention & Chronic Conditions

Heart Failure
Predicting LVEF Improvement After AF Catheter Ablation
Author(s): Nikhil Ahluwalia , Ahmed Hussain , Rui Providencia , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Heart Failure
Genetic Link to CVD in Hypertensive Pregnancy
Added: 5 months ago Source:  Radcliffe Cardiology
Observational studies have long suggested that women who experience hypertensive disorders of pregnancy (HDP) face a greater risk of cardiovascular disease (CVD) later in life. A new genetic epidemiological study has explored whether this association is causal, using Mendelian randomization (MR) to investigate the genetic underpinnings of this risk. The findings suggest a genetic predisposition… View more

MI/ACS

Prevention & Chronic Conditions
The Future of Heart Valve Treatment: Proven Therapies and Patient Impact
Author(s): Brian O’Neill, Bryan Zweig, Ryan Gindi Start date: Apr 03, 2025
Join us for an exclusive webinar, part of the Beyond the Heartbeat series, that delves into the latest advancements in mitral and tricuspid regurgitation treatment. Our expert panel will equip you with details related to groundbreaking clinical trial data and practical insights to enhance your professional practice.Learning Objectives:Explore Proven Therapies: Discover recent clinical data from… View more

Intervention

Guidelines & Statements